Jaka jest cena za Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Cena za Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) wynosi $1.15

Jaka jest kapitalizacja rynkowa dla Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Kapitalizacja rynkowa dla Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) wynosi $88.79M

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) Akcje w Obiegu

Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.

Rok	Akcje w obrocie	Zmień
Za mało danych dla podanych dat.

Rok

Akcje w obrocie

Zmień

Za mało danych dla podanych dat.

Firma	Akcje w obrocie	Różnica	Kraj
Royalty Pharma plc RPRX.US	445.06M	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Corcept Therapeutics Incorporated CORT.US	105.38M	-	US
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	-	IT

Firma

Akcje w obrocie

Różnica

Kraj